Johnson & Johnson Ordered to Pay $1.8 Million for Injuries Caused by Levaquin

more+
less-

A federal court recently ordered Johnson & Johnson to pay $1.8 million – $700,000 in actual damages and $1.1 million in punitive damages – to an 82-year-old man from Minnesota who claimed that he was injured by the antibiotic Levaquin. The drug is an antibiotic used to treat infections such as pneumonia and chronic bronchitis, as well as sinus, urinary tract, kidney, prostate and skin infections.

The drug has been known to cause complications including tendon damage, Achilles tendon rupture, inflammation, Achilles tendonitis, and injury to the rotator cuff, biceps, hand and thumb that may require extensive surgery and could leave the patient incapacitated and facing large medical bills. In this case, the plaintiff was prescribed Levaquin in 2005 to treat bronchitis but after just three days of use, the plaintiff’s Achilles’ tendons ruptured. In 2008, the U.S. Food & Drug Administration required Johnson & Johnson and manufacturers of generic forms of the drug to print warnings about the drug’s risk of tendon injuries.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Howard Ankin | Attorney Advertising

Written by:

more+
less-

Howard Ankin on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×